The first category, growth-hormone secretagogues such as CJC-1295 and Ipamorelin, is proposed to stimulate the pituitary gland's own growth-hormone release and downstream IGF-1 output, an approach tied to lean mass and recovery support in the research reviewed for this list
They do not contain or replace estrogen, they are not a substitute for hormone replacement therapy, and neither is FDA approved
Asked by a reporter why he will not release the sequence, Sikiri's answer was telling: "If you have your own child, you want it to be yours forever." The more ordinary knowledge gaps are large too
By upregulating angiogenic factors like VEGF, it boosts blood flow and nutrient delivery, ensuring better oxygen and nourishment to the ovaries, uterus, and testes
Deciding if a treatment is a good fit for your goals is a personal process